Home
>
National Drug Code (NDC)
>
TOPIRAMATE
TOPIRAMATE - 13668-031-53 - (topiramate)
Drug Information of TOPIRAMATE
| Product NDC: | 13668-031 |
| Proprietary Name: | TOPIRAMATE |
| Non Proprietary Name: | topiramate |
| Active Ingredient(s): | 25 mg/1 & nbsp; topiramate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TOPIRAMATE
| Product NDC: | 13668-031 |
| Labeler Name: | Torrent Pharmaceuticals Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079153 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090327 |
Package Information of TOPIRAMATE
| Package NDC: | 13668-031-53 |
| Package Description: | 9000 TABLET in 1 BOTTLE (13668-031-53) |
NDC Information of TOPIRAMATE
| NDC Code | 13668-031-53 |
| Proprietary Name | TOPIRAMATE |
| Package Description | 9000 TABLET in 1 BOTTLE (13668-031-53) |
| Product NDC | 13668-031 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | topiramate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090327 |
| Marketing Category Name | ANDA |
| Labeler Name | Torrent Pharmaceuticals Limited |
| Substance Name | TOPIRAMATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
